Kevin J. Heyeck

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.

Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts.

Dreamers Factory Innovacion Outpost SL (Dreamers Factory) is a venture capital firm founded in 2019 by Jose Antonio Borge, Eneko Knörr and Gorka Fius. The firm is headquartered in Spain with an additional office in the US.

Safavi Applied Life Sciences LLC is a private company that provides versatile workspace shells for medical, dental, or therapy practices to customize their environment. The company is based in Englewood, CO and has subsidiaries in the United States. The company offers build-to-suit workspaces to help innovators start up faster. The company has over one million square feet of built-to-suit laboratories and workspaces for lease being planned and built along the I-25 corridor. The CEO of the company is Afshin Safavi.

BALX Holdings LLC operates as a biotechnology firm which offers health care services. The company was incorporated in 2013 and is headquartered in Boston, MA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

BioAgilytix Labs LLC engages in the provision of specialized bioanalytical testing laboratory. It offers gene therapy, biosimilars, antibody drug conjugates and immuno-oncology solutions. The company was founded by Afshin Safavi in 2008 and is headquartered in Durham, NC.

eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium.

Walking Fish Therapeutics, Inc. engages in the provision of immune therapy services. It offers treatment for oncology, rare deficiency disease, regenerative medicine, and infectious disease. The company was founded by Lewis T. Williams, Mark Selby, Seenu Kothakota, and Tom Brennan and is headquartered in South San Francisco, CA.

Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom.

Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA.

Artá Capital SGEIC SA (Artá Capital) is a private equity arm of Artá Partners SA founded in 2007. The firm is headquartered in Madrid, Spain.